Medications for Pneumocystis Pneumonia
27 results
Atovaquone (atovaquone)
(Atovaquone)Camber Pharmaceuticals, Inc.
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to this population and condition.
Atovaquone (atovaquone)
(Atovaquone)Bionpharma Inc.
Usage: Atovaquone oral suspension is indicated for preventing and treating mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (≥13 years) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to mild-to-moderate cases, with no studies for severe PCP or TMP-SMX failures.
Atovaquone (atovaquone)
(Atovaquone)PAI Holdings, LLC
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (aged 13 and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Limited clinical experience exists for severe PCP cases or treatment failures with TMP-SMX.
Atovaquone (atovaquone)
(Atovaquone)AvPAK
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to mild-to-moderate cases.
Atovaquone (atovaquone)
(Atovaquone)Avion Pharmaceuticals, LLC
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (age 13 and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to cases categorized as mild-to-moderate PCP.
Atovaquone (atovaquone)
(atovaquone)NorthStar RxLLC
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (13 years and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Efficacy for severe PCP or in treatment failures with TMP-SMX has not been established.
Atovaquone (atovaquone)
(Atovaquone)Kesin Pharma
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (aged 13 and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to mild-to-moderate cases and unstudied for severe PCP.
Atovaquone oral suspension (atovaquone)
(Atovaquone)KVK-Tech Inc
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Efficacy in severe cases or those failing TMP-SMX therapy is not established.
Mepron (atovaquone)
(atovaquone)GlaxoSmithKline LLC
Usage: MEPRON is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (ages 13+) who cannot tolerate trimethoprim-sulfamethoxazole. Its use for more severe cases of PCP or in patients failing TMP-SMX therapy has not been studied.
Pentam 300 (pentamidine isethionate)
(PENTAMIDINE ISETHIONATE)Fresenius Kabi USA, LLC
Usage: Pentam 300 (pentamidine isethionate for injection) is indicated for the treatment of pneumonia caused by *Pneumocystis carinii*.